Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis

OBJECTIVE: This observational cohort study investigated the impact of biological (b) disease-modifying antirheumatic drugs (DMARDs) on the outcomes of serious infections (SIs) in patients with rheumatoid arthritis. METHODS: We investigated outcomes of SIs observed in 947 patients enrolled in the Ger...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, A, Listing, J, Schneider, M, Klopsch, T, Kapelle, A, Kaufmann, J, Zink, A, Strangfeld, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013078/
https://www.ncbi.nlm.nih.gov/pubmed/26567181
http://dx.doi.org/10.1136/annrheumdis-2015-207838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013078/
https://www.ncbi.nlm.nih.gov/pubmed/26567181
http://dx.doi.org/10.1136/annrheumdis-2015-207838

Ejemplares similares